-
-
[1]EckardtKU .Renalfailureinliverdisease[J].IntensiveCareMed, 1999, 25∶5. [2] WatanabeM , OzakiT , HirataY , etal.Mechanismforloweringbloodammonialevelsbylactitol[J].JpnJPharmacol, 1995, 4∶369-74. [3] GinesP , GuevaraM .Goodnewsforhepatorenalsyndrome[J].Hepatolo gy, 2002, 36 (2) ∶504-506. [4] AguillonD , SeguinP , MalledantY .Hepatorenalsyndrome:fromphys iopathologytotreatment[J].AnnFrAnesthReanim, 2003, 1∶30-8. [5] LenzK , DrumlW , KleinbergerG , etal.Enhancementofrenalfunctionwithornipressininapatientwithdecompensatedcirrhosis[J].Gut, 1985, 26 (12) ∶1385-6. [6] LenzK , HortnaglH , DrumlW , etal.Ornipressininthetreatmentoffunctionalrenalfailureindecompensatedelivercirrhosis[J].Gastroen terology, 1991, 101∶1060. [7] GuevaraM , GinesP , FemrdezEG , etal.Reversibilityofhepatorenalsyndromebyprolongedadministrationofornipressinandplasmavolumeexpression[J].Hepatology, 1998, 27∶35. [8] HadengueA , Gadao, GiostraE , etal.Terilpressininthetreatmentofhepatorenalsyndrome:Adoubleblindcrossoverstudy[J].Hepatology, 1995, 22 (A236) ∶165. [9] HadengueA , GadanoA , MoreauR , etal.Beneficialeffectsofthe2daysadministrationofterlipressininpatientswithcirrhosisandhepatore nalsyndrome[J].JHepatol, 1998, 29∶565. [10] OrtegaR , GinesP , UrizJ , etal.Terlipressintherapywithandwithoutalbuminforpatientswithhepatorentalsyndrome:resultsofaprospective, nonrandomizedstudy[J].Hepatology, 2002, 36 (4) ∶941-948. [11] SolankiP , ChawlaA , GargR , etal.Beneficialeffectsofterlipressininhepatorenalsyndrome:aprospective, randomizedplacebo-controlledclinicaltrial[J].JGastroenterolHepatol, 2003, 18 (2) ∶152-6. [12] KaffyF , BorderieC , ChagneauC , etal.Octreotideinthetreatmentofthehepatorenalsyndromeincirrhoticpatients[J].JHepatol, 1999, 30 (1) ∶174. [13] AngeliP , VolpinR , GerundaG , etal.Reversaloftype1hepatorenalsyndromewiththeadministrationofmidodrineandoctreotide[J].Hepatol ogy, 1999, 29 (6) ∶1690-7. [14] FeveryJ, Van-CutsemE , NevensF , etal.Reversalofhepatorenalsyndromeinfourpatientsbyperoralmisoprostol (prostaglandinE1ana logue) andalbuminadministration[J].JHepatol, 1990, 11 (2) ∶153-8. [15] ClewellJD , Walker-RenardP .Prostaglandinsforthetreatmentofhepatorenalsyndrome[J].AnnPharmacother, 1994, 28 (1) ∶54-5. [16] DuvouxC , ZanditenasD , HezodeC , etal.EffectsofnoradrenalinandalbumininpatientswithtypeⅠhepatorenalsyndrome:apilotstudy[J].2002, 36 (2) ∶374-380. [17] CapellaGL .Anti-leukotrienedrugsinthepreventionandtreatmentofhepatorenalsyndrome[J].ProstaglandinsLeukotEssentFattyAcids, 2003, 68 (4) ∶263-5.
本文二维码
计量
- 文章访问数: 2081
- HTML全文浏览量: 3
- PDF下载量: 800
- 被引次数: 0